Tim Hwang
Tim Hwang
About
Detail
Vice President, B2B Marketing (Fractional)
California, United States
Professional marketing executive with a track record for growing emerging and established health and technology brands over the past 18+ years. Expert in creating product marketing and commercialization strategies, including competitive positioning and innovative multi-channel tactical plans. Successful senior people leader with ability to build long-standing, high-value B2B relationships with commercial executives and key opinion leaders.
-In 2022-2023, evolved global position for B2B SaaS mental health solution, yielding nearly double annual recurring revenue YoY thanks to strong collaboration with sales and product teams.
-In 2018-2021, created and managed a $50m+ strategic brand/tactical plan, equating to 250% YoY growth for a multi-indication lung cancer product in a highly competitive marketplace.
-In 2016, launched “first-in-class” anti PD-L1 agent in immuno-oncology, leading the team through 6 line extension indications across early and late stage lung cancers.
-In 2014, launched a novel diagnostic/testing business franchise, inclusive of tripling the national field team and creating a new, product-agnostic educational brand marketing campaign to target pathologists and oncologists.
Specialties: Brand and Business Development, Strategic Planning for Brands with Growth Needs, Product Positioning and Strategy, AI, Biotech/Pharmaceuticals, Entertainment/Social/Emerging Media, PR, Communications, Management Consulting, Establishing and Leading Teams.
-In 2022-2023, evolved global position for B2B SaaS mental health solution, yielding nearly double annual recurring revenue YoY thanks to strong collaboration with sales and product teams.
-In 2018-2021, created and managed a $50m+ strategic brand/tactical plan, equating to 250% YoY growth for a multi-indication lung cancer product in a highly competitive marketplace.
-In 2016, launched “first-in-class” anti PD-L1 agent in immuno-oncology, leading the team through 6 line extension indications across early and late stage lung cancers.
-In 2014, launched a novel diagnostic/testing business franchise, inclusive of tripling the national field team and creating a new, product-agnostic educational brand marketing campaign to target pathologists and oncologists.
Specialties: Brand and Business Development, Strategic Planning for Brands with Growth Needs, Product Positioning and Strategy, AI, Biotech/Pharmaceuticals, Entertainment/Social/Emerging Media, PR, Communications, Management Consulting, Establishing and Leading Teams.